Home » Topics » BioWorld Science

BioWorld Science
RSS

Camostat mesylate does not lead to significant improvement in patients hospitalized with COVID-19

May 18, 2021

Antibody-cytokine chimera shows promise in vivo for melanoma

May 18, 2021

Unity opens enrollment in phase IIa study of UBX-1325 in DME

May 18, 2021

Data presented from low-dose cohort of first-in-human trial FX-201

May 18, 2021

Promising effect of oral TRPC6 inhibitor BI-749327 on pulmonary hypertension

May 18, 2021

Ono Pharmaceutical and The Vanderbilt University divulge potassium channel modulators

May 18, 2021

Accent Therapeutics presents METTL3 inhibitors

May 18, 2021

Rodin Therapeutics identifies new HDAC inhibitors

May 18, 2021

Interim phase I data for scAAV-2.5-IL1R as local gene therapy in OA of the knee

May 18, 2021

Chromosomal fusion - an ALTernative tumor target for PARP inhibitors?

May 18, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...